Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
M302985-5mg | 5mg | In stock | $103.90 | |
M302985-10mg | 10mg | In stock | $155.90 | |
M302985-25mg | 25mg | In stock | $351.90 | |
M302985-50mg | 50mg | In stock | $456.90 | |
M302985-100mg | 100mg | In stock | $822.90 | |
M302985-200mg | 200mg | Available within 1-2 weeks(?) Item is derived from our semi-finished stock and is processed in 1-2 weeks. | $1,480.90 |
Potent matrix metalloproteinase inhibitor
Synonyms | Marimastat|154039-60-8|BB-2516|BB 2516|Marimastat (BB-2516)|BB2516|D5EQV23TDS|(2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',3-dihydroxy-2-(2-methylpropyl)butanediamide|(2R,3S)-N1-((S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl)-N4,3-d |
---|---|
Specifications & Purity | 99% |
Storage Temp | Store at -20°C |
Shipped In | Dry ice |
Action Type | INHIBITOR |
Mechanism of action | Matrix metalloproteinase 7 inhibitor |
ALogP | 0.5 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488187602 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488187602 |
IUPAC Name | (2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',3-dihydroxy-2-(2-methylpropyl)butanediamide |
INCHI | InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1 |
InChi Key | OCSMOTCMPXTDND-OUAUKWLOSA-N |
Canonical SMILES | CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C |
Isomeric SMILES | CC(C)C[C@H]([C@@H](C(=O)NO)O)C(=O)N[C@H](C(=O)NC)C(C)(C)C |
PubChem CID | 119031 |
Molecular Weight | 331.41 |
CAS Registry No. | 154039-60-8 |
---|---|
DrugBank Ligand | DB00786 |
Wikipedia | Marimastat |
ChEBI | CHEBI:50662 |
PubChem CID | 119031 |
ChEMBL Ligand | CHEMBL279785 |
RCSB PDB Ligand | 97, 097 |
PubChem SID | 488187602 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
Certificate of Analysis | Mar 13, 2023 | M302985 | |
Certificate of Analysis | Mar 13, 2023 | M302985 | |
Certificate of Analysis | Mar 13, 2023 | M302985 | |
Certificate of Analysis | Mar 13, 2023 | M302985 | |
Certificate of Analysis | Mar 13, 2023 | M302985 | |
Certificate of Analysis | Mar 13, 2023 | M302985 | |
Certificate of Analysis | Mar 13, 2023 | M302985 | |
Certificate of Analysis | Mar 13, 2023 | M302985 | |
Certificate of Analysis | Mar 13, 2023 | M302985 | |
Certificate of Analysis | Mar 13, 2023 | M302985 | |
Certificate of Analysis | Mar 13, 2023 | M302985 | |
Certificate of Analysis | Mar 13, 2023 | M302985 |
Solubility | DMSO: ≥20 mg/mL |
---|---|
Melt Point(°C) | 148°C |
Starting at $33.90
Starting at $58.90
Starting at $151.90
Starting at $1,198.90
Starting at $103.90
Starting at $18.90
Starting at $75.90
Starting at $813.90
Starting at $64.90
Starting at $296.90
Starting at $111.90
Starting at $296.90
Starting at $112.90
Starting at $78.90
Starting at $75.90
Starting at $16.90
Starting at $74.90
1. Steward WP, Thomas AL. (2000) Marimastat: the clinical development of a matrix metalloproteinase inhibitor.. Expert Opin Investig Drugs, 9 (12): (2913-22). [PMID:11093361] |
2. Williams HF, Layfield HJ, Vallance T, Patel K, Bicknell AB, Trim SA, Vaiyapuri S. (2019) The Urgent Need to Develop Novel Strategies for the Diagnosis and Treatment of Snakebites.. Toxins (Basel), 11 (6): (589-97). [PMID:31226842] |
3. Layfield HJ, Williams HF, Ravishankar D, Mehmi A, Sonavane M, Salim A, Vaiyapuri R, Lakshminarayanan K, Vallance TM, Bicknell AB et al.. (2020) Repurposing Cancer Drugs Batimastat and Marimastat to Inhibit the Activity of a Group I Metalloprotease from the Venom of the Western Diamondback Rattlesnake, Crotalus atrox.. Toxins (Basel), 12 (5): (589-97). [PMID:32397419] |
4. Rasmussen HS, McCann PP. (1997) Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat.. Pharmacol Ther, 75 (1): (69-75). [PMID:9364582] |
5. Minutti CM et al.. (2017) Epidermal Growth Factor Receptor Expression Licenses Type-2 Helper T Cells to Function in a T Cell Receptor-Independent Fashion.. Immunity, 47 (4): (710-722.e6). [PMID:29045902] |